The Grand Prix d’Horlogerie de Genève award ceremony is the most hotly anticipated event of the Swiss watch industry calendar ...

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Pharmaceutical Factory America, a subsidiary of Otsuka Pharmaceutical Factory, has ...

In a report released today, Hiroko Sato from Jefferies maintained a Buy rating on Otsuka (OSUKF – Research Report), with a price target of Yen4,400.00. The company’s shares closed last Thursday at $41 ...

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Pharmaceutical Factory America, a subsidiary of Otsuka Pharmaceutical Factory, has partnered with ICU Medical to form a joint venture in ...

Sasaki is considered one of the best pitchers in the world. His market will include all 30 teams, notably the Phillies, who ...

Sugarcane’ leads the nominations for the Cinema Eye Honors awards with six. Four films are next with five each: ‘Dahomey,’ ...

Japan's Otsuka Pharma has agreed to take control of US biotech Jnana Therapeutics in a deal that will give it rights to a clinical-stage candidate for the rare metabolic disorder phenylketonuria ...

DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Otsuka licensed rights to Lupkynis in various ex-US markets including the EU, Japan and the UK in 2020, with Aurinia retaining rights to the drug in the US and its home market of Canada.

The glucose syrup market is largely driven by its rising demand within the food and beverage industry. Furthermore, the expanding uses and benefits of glucose syrup in the pharmaceutical sector ...